LONDON — Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's LLY.N obesity drug ...
Novo Nordisk NVO announced that it plans to invest DKK 8.5 billion, translating to approximately $1.2 billion, to set up a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback